JDRF and TrialReach Launch a New, No Cost Clinical Trial Matching Tool to Solve Critical Challenges in Diabetes Research
![Schematic representation of the balance of clinical trial activity in... | Download Scientific Diagram Schematic representation of the balance of clinical trial activity in... | Download Scientific Diagram](https://www.researchgate.net/publication/46095334/figure/fig1/AS:601631401988135@1520451512548/Schematic-representation-of-the-balance-of-clinical-trial-activity-in-type-1-diabetes.png)
Schematic representation of the balance of clinical trial activity in... | Download Scientific Diagram
INNODIA set to speed up clinical trials for type 1 diabetes drugs | IMI Innovative Medicines Initiative
World-first gene therapy clinical trial for type 1 diabetes to proceed | Garvan Institute of Medical Research
![Joint Research Collaboration Aims to Advance Human Clinical Trials for the Treatment of Hypoglycemic Unawareness Patients with Severe Type 1 Diabetes Joint Research Collaboration Aims to Advance Human Clinical Trials for the Treatment of Hypoglycemic Unawareness Patients with Severe Type 1 Diabetes](https://bioinformant.com/wp-content/uploads/2016/07/17727298_m.jpg)
Joint Research Collaboration Aims to Advance Human Clinical Trials for the Treatment of Hypoglycemic Unawareness Patients with Severe Type 1 Diabetes
![Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes | Nature Reviews Immunology Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes | Nature Reviews Immunology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnri2705/MediaObjects/41577_2010_Article_BFnri2705_Fig1_HTML.jpg)
Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes | Nature Reviews Immunology
![Effect of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes: 24-month results from the randomised ALERTT1 trial - The Lancet Diabetes & Endocrinology Effect of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes: 24-month results from the randomised ALERTT1 trial - The Lancet Diabetes & Endocrinology](https://www.thelancet.com/cms/attachment/413484cd-7809-4795-b3d5-9eea38cf98cc/gr1_lrg.jpg)